| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.8 | 0.002 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.43 | 0.007 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.41 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.35 | 0.04 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.35 | 0.04 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.33 | 0.05 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.29 | 0.07 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |